Integra Lifesciences Holdings Corp (IART)
22.99
+0.06
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Revenue (Quarterly): 380.83M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 380.83M |
| June 30, 2024 | 418.18M |
| March 31, 2024 | 368.87M |
| December 31, 2023 | 397.04M |
| September 30, 2023 | 382.42M |
| June 30, 2023 | 381.27M |
| March 31, 2023 | 380.85M |
| December 31, 2022 | 398.02M |
| September 30, 2022 | 385.19M |
| June 30, 2022 | 397.82M |
| March 31, 2022 | 376.64M |
| December 31, 2021 | 405.52M |
| September 30, 2021 | 386.86M |
| June 30, 2021 | 389.99M |
| March 31, 2021 | 360.07M |
| December 31, 2020 | 388.65M |
| September 30, 2020 | 370.23M |
| June 30, 2020 | 258.66M |
| March 31, 2020 | 354.32M |
| December 31, 2019 | 395.13M |
| September 30, 2019 | 379.10M |
| June 30, 2019 | 383.64M |
| March 31, 2019 | 359.69M |
| December 31, 2018 | 383.32M |
| September 30, 2018 | 365.85M |
| Date | Value |
|---|---|
| June 30, 2018 | 366.19M |
| March 31, 2018 | 357.08M |
| December 31, 2017 | 368.60M |
| September 30, 2017 | 278.83M |
| June 30, 2017 | 282.16M |
| March 31, 2017 | 258.64M |
| December 31, 2016 | 255.66M |
| September 30, 2016 | 250.33M |
| June 30, 2016 | 249.31M |
| March 31, 2016 | 236.77M |
| December 31, 2015 | 241.16M |
| September 30, 2015 | 226.37M |
| June 30, 2015 | 212.67M |
| March 31, 2015 | 202.53M |
| December 31, 2014 | 219.07M |
| September 30, 2014 | 197.52M |
| June 30, 2014 | 231.35M |
| March 31, 2014 | 215.06M |
| December 31, 2013 | 81.39M |
| September 30, 2013 | 213.25M |
| June 30, 2013 | 205.55M |
| March 31, 2013 | 196.65M |
| December 31, 2012 | 214.43M |
| September 30, 2012 | 210.08M |
| June 30, 2012 | 210.17M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
258.66M
Minimum
Jun 2020
418.18M
Maximum
Jun 2024
378.83M
Average
383.81M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Haemonetics Corp | 345.51M |
| ResMed Inc | 1.225B |
| Globus Medical Inc | 625.70M |
| Perspective Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.70M |
| Total Expenses (Quarterly) | 388.98M |
| EPS Diluted (Quarterly) | -0.14 |
| Enterprise Value | 3.298B |
| Gross Profit Margin (Quarterly) | 52.58% |
| Profit Margin (Quarterly) | -2.81% |
| Earnings Yield | -0.39% |
| Operating Earnings Yield | 1.62% |
| Normalized Earnings Yield | -0.3915 |